These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 17495790

  • 21. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.
    Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, Liu CC, Lee IH, Wu TC, Wu SF, Ni YH, Hsu HY, Chen DS, Chang MH.
    Hepatology; 2004 Jan; 39(1):58-63. PubMed ID: 14752823
    [Abstract] [Full Text] [Related]

  • 22. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S.
    Lakartidningen; 2000 Aug 30; 97(35):3738-40. PubMed ID: 11016226
    [Abstract] [Full Text] [Related]

  • 23. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Zhao Z, Murphy TV, Jacques-Carroll L.
    Vaccine; 2011 Dec 09; 30(1):14-20. PubMed ID: 22063390
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B vaccination coverage among adults--United States, 2004.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 May 12; 55(18):509-11. PubMed ID: 16691181
    [Abstract] [Full Text] [Related]

  • 25. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z, Zhu Y, Stjernsward J, Hilleman M, Collins R, Zhen Y, Hsia CC, Lu J, Huang F, Ni Z.
    Cancer Detect Prev; 1991 May 12; 15(4):313-8. PubMed ID: 1665400
    [Abstract] [Full Text] [Related]

  • 26. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
    Yu W, Liu D, Zheng J, Liu Y, An Z, Rodewald L, Zhang G, Su Q, Li K, Xu D, Wang F, Yuan P, Xia W, Ning G, Zheng H, Chu Y, Cui J, Duan M, Hao L, Zhou Y, Wu Z, Zhang X, Cui F, Li L, Wang H.
    Int J Epidemiol; 2016 Apr 12; 45(2):441-9. PubMed ID: 27174834
    [Abstract] [Full Text] [Related]

  • 27. Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data--United States.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Apr 08; 60(13):410-3. PubMed ID: 21471948
    [Abstract] [Full Text] [Related]

  • 28. Newborn hepatitis B vaccination coverage among children born January 2003-June 2005--United States.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Aug 01; 57(30):825-8. PubMed ID: 18668021
    [Abstract] [Full Text] [Related]

  • 29. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S, Begier EM, Schech SD, Venus P, Shatin D, Braun MM, Ball R.
    Pediatr Infect Dis J; 2007 Apr 01; 26(4):329-33. PubMed ID: 17414397
    [Abstract] [Full Text] [Related]

  • 30. Control of hepatitis B in China: prevention and treatment.
    Wang Y, Jia J.
    Expert Rev Anti Infect Ther; 2011 Jan 01; 9(1):21-5. PubMed ID: 21171874
    [Abstract] [Full Text] [Related]

  • 31. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W, Liang X, Cui F, Li L, Hadler SC, Hutin YJ, Kane M, Wang Y.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [Abstract] [Full Text] [Related]

  • 32. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z, Li L, Ruan B.
    Int J Infect Dis; 2012 Feb 27; 16(2):e82-8. PubMed ID: 22178658
    [Abstract] [Full Text] [Related]

  • 33. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992-2006: A mathematical model analysis.
    Liang P, Zu J, Yin J, Li H, Gao L, Cui F, Wang F, Liang X, Zhuang G.
    J Theor Biol; 2015 Dec 07; 386():115-21. PubMed ID: 26375372
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Epidemiology and prevention of hepatitis B.
    Alter MJ.
    Semin Liver Dis; 2003 Feb 07; 23(1):39-46. PubMed ID: 12616449
    [Abstract] [Full Text] [Related]

  • 36. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
    Zhang L, Ko S, Lv J, Ji F, Yan B, Xu F, Xu A.
    Hum Vaccin Immunother; 2014 Feb 07; 10(9):2755-60. PubMed ID: 25483482
    [Abstract] [Full Text] [Related]

  • 37. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S, Xu Z, Lu Y.
    Int J Epidemiol; 2000 Aug 07; 29(4):744-52. PubMed ID: 10922354
    [Abstract] [Full Text] [Related]

  • 38. [Study on the influencing factors of hepatitis B vaccine timely birth dose for infants born at hospitals].
    Hu YS, Ding ZR, Huang GF.
    Zhongguo Yi Miao He Mian Yi; 2009 Oct 07; 15(5):404-8. PubMed ID: 20084964
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hepatitis B virus infection.
    Chang MH.
    Semin Fetal Neonatal Med; 2007 Jun 07; 12(3):160-7. PubMed ID: 17336170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.